Czech National Bank Organon & Co. Transaction History

Czech National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$16.59 - $23.77 $240,123 - $344,046	14,474 Added 47.94%	44,668 $775,000
Q2 2023 Jul 11, 2023	BUY	$19.27 - $24.63 $4,393 - $5,615	228 Added 0.76%	30,194 $628,000
Q1 2023 Apr 17, 2023	BUY	$21.42 - $32.08 $4,112 - $6,159	192 Added 0.64%	29,966 $704,000
Q4 2022 Jan 18, 2023	BUY	$23.31 - $28.61 $5,058 - $6,208	217 Added 0.73%	29,774 $0
Q3 2022 Oct 31, 2022	BUY	$23.4 - $34.25 $691,633 - $1.01 Million	29,557 New	29,557 $692,000

790

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.03B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Czech National Bank, based on Form 13F filings with the SEC.

Stay updated on Czech National Bank with notifications on news.